SonaCare Medical LLC will go before FDA’s Gastroenterology and Urology Devices Panel with its Sonablate 450 high intensity focused ultrasound device for prostate cancer on Oct. 1.
The Charlotte, North Carolina, firm is seeking PMA approval to sell the device to treat localized prostate cancer that has recurred after an initial round of radiation therapy. The company...